China investors step up focus on medtech, healthcare services
This article was originally published in Clinica
Executive Summary
Medical devices, clinical services and mHealth technology took a significant chunk of the near-$2m that went into healthcare-related investment in China last year, according to Zero2IPO, a local private equity fund. While pharmaceuticals still accounted for 46% of total M&A investment, medical devices came second with 33% and health services made up the remainder.